Keyphrases
Small Molecule Inhibitors
100%
C-Met
100%
Ovarian Cancer Cells
100%
PHA665752
100%
Cisplatin
45%
Gene Silencing
18%
Ovarian Cancer
18%
SKOV3
18%
OVCAR-3
18%
Flow Cytometry
9%
Small Interfering RNA (siRNA)
9%
Tumorigenesis
9%
Phosphorylation
9%
Cancer Cells
9%
Cell Proliferation
9%
Cell Growth
9%
Cell Apoptosis
9%
Therapeutic Approaches
9%
Human Tumors
9%
Proliferation Inhibition
9%
Induced Apoptosis
9%
Induced Proliferation
9%
Western Blotting
9%
Transient Activation
9%
Tyrosine Kinase Receptor
9%
Cisplatin-induced
9%
Protein Expression Level
9%
Proliferation Apoptosis
9%
Resistance to Chemotherapy
9%
Metastatic Spread
9%
Methyl Thiazolyl Tetrazolium Assay
9%
Adverse Prognosis
9%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Cancer Cell
100%
Cisplatin
100%
Western Blot
14%
Gene Silencing
14%
Small Interfering RNA
14%
Cell Proliferation
14%
Carcinogenesis
14%
Cell Growth
14%
Flow Cytometry
14%
Tyrosine Kinase Receptor
14%
Protein Expression Level
14%
Phosphor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Cisplatin
100%
Scatter Factor Receptor
28%
Malignant Neoplasm
14%
Flow Cytometry
14%
Neoplasm
14%
Carcinogenesis
14%
Chemotherapy
14%
Western Blot
14%
Small Interfering RNA
14%
Tetrazolium
14%
Tyrosine Kinase Receptor
14%
Phosphorus
14%
Medicine and Dentistry
5 (2,6 Dichlorobenzylsulfonyl) 3 [3,5 Dimethyl 4 [2 (1 Pyrrolidinylmethyl) 1 Pyrrolidinylcarbonyl] 1h Pyrrol 2 Ylmethylene] 1,3 Dihydro 2h Indol 2 One
100%
Scatter Factor Receptor
28%
OV-90 Cell Line
14%
Immunology and Microbiology
5 (2,6 Dichlorobenzylsulfonyl) 3 [3,5 Dimethyl 4 [2 (1 Pyrrolidinylmethyl) 1 Pyrrolidinylcarbonyl] 1h Pyrrol 2 Ylmethylene] 1,3 Dihydro 2h Indol 2 One
100%
OV-90 Cell Line
33%